Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions

NCT01827878 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Fed

Interventions

DRUG: Lisinopril and Hydrochlorothiazide Tablets (20+25) mg
DRUG: Zestoretic® 20/25 lisinopril/hydrochlorothiazide Tablets

Sponsor

IPCA Laboratories Ltd.